{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:46:56Z","timestamp":1768315616699,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.thromres.2011.01.009","type":"journal-article","created":{"date-parts":[[2011,2,13]],"date-time":"2011-02-13T11:40:23Z","timestamp":1297597223000},"page":"576-581","source":"Crossref","is-referenced-by-count":16,"title":["Homocysteinylated fibrinogen forms disulfide-linked complexes with albumin"],"prefix":"10.1016","volume":"127","author":[{"given":"Derrick L.","family":"Sauls","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureane","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2011.01.009_bb0005","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"issue":"18","key":"10.1016\/j.thromres.2011.01.009_bb0010","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1161\/01.CIR.99.18.2383","article-title":"Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)","volume":"99","author":"McQuillan","year":"1999","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.thromres.2011.01.009_bb0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.274.13.1049","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.thromres.2011.01.009_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MCA.0b013e3282f52910","article-title":"Homocysteine predicts adverse clinical outcomes in unstable angina and non-ST elevation myocardial infarction: implications from the folate intervention in non-ST elevation myocardial infarction and unstable angina study","volume":"19","author":"Nevado","year":"2008","journal-title":"Coron Artery Dis"},{"issue":"2","key":"10.1016\/j.thromres.2011.01.009_bb0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1751-7141.2008.08293.x","article-title":"Elevated levels of homocysteine predict cardiovascular death, nonfatal myocardial infarction, and symptomatic bypass graft disease at 2-year follow-up following coronary artery bypass surgery","volume":"11","author":"Shammas","year":"2008","journal-title":"Prev Cardiol"},{"issue":"8","key":"10.1016\/j.thromres.2011.01.009_bb0030","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/bjs.1800810811","article-title":"Impaired homocysteine metabolism: a risk factor in young adults with atherosclerotic arterial occlusive disease of the leg","volume":"81","author":"Aronson","year":"1994","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.thromres.2011.01.009_bb0035","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1538-7836.2003.00053.x","article-title":"Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia","volume":"1","author":"Sauls","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2011.01.009_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.thromres.2006.08.001","article-title":"Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia","volume":"120","author":"Sauls","year":"2007","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.thromres.2011.01.009_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.mbc.0000220238.99843.45","article-title":"Influence of homocysteine on fibrin network lysis","volume":"17","author":"Lauricella","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"10.1016\/j.thromres.2011.01.009_bb0050","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/01.ATV.0000219688.43572.75","article-title":"Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects","volume":"26","author":"Undas","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.thromres.2011.01.009_bb0055","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/j.1538-7836.2007.02637.x","article-title":"Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine","volume":"5","author":"Undas","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.thromres.2011.01.009_bb0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/187152508784871981","article-title":"Alterations of fibrinogen structure in human disease","volume":"6","author":"Hoffman","year":"2008","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"2","key":"10.1016\/j.thromres.2011.01.009_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1160\/TH07-06-0404","article-title":"Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen","volume":"99","author":"Marchi","year":"2008","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.thromres.2011.01.009_bb0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3233\/BIR-2009-0459","article-title":"Homocysteine modifies fibrin clot deformability: another possible explanation of harm","volume":"46","author":"Rojas","year":"2009","journal-title":"Biorheology"},{"issue":"1","key":"10.1016\/j.thromres.2011.01.009_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0038-1653741","article-title":"Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen","volume":"73","author":"Haverkate","year":"1995","journal-title":"Thromb Haemost"},{"issue":"2S Suppl","key":"10.1016\/j.thromres.2011.01.009_bb0080","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1093\/jn\/130.2.377S","article-title":"Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans","volume":"130","author":"Jakubowski","year":"2000","journal-title":"J Nutr"},{"issue":"6","key":"10.1016\/j.thromres.2011.01.009_bb0085","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/bc00018a009","article-title":"Acidic derivatives of homocysteine thiolactone: utility as anionic linkers","volume":"3","author":"Leanza","year":"1992","journal-title":"Bioconjug Chem"},{"issue":"11","key":"10.1016\/j.thromres.2011.01.009_bb0090","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/rcm.681","article-title":"Homocysteine thiolactone and protein homocysteinylation: mechanistic studies with model peptides and proteins","volume":"16","author":"Hop","year":"2002","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"15","key":"10.1016\/j.thromres.2011.01.009_bb0095","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1096\/fasebj.13.15.2277","article-title":"Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels","volume":"13","author":"Jakubowski","year":"1999","journal-title":"FASEB J"},{"issue":"8","key":"10.1016\/j.thromres.2011.01.009_bb0100","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1021\/bi052076j","article-title":"Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia","volume":"45","author":"Sauls","year":"2006","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.thromres.2011.01.009_bb0105","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.STR.0000128412.59768.6e","article-title":"Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis","volume":"35","author":"Undas","year":"2004","journal-title":"Stroke"},{"issue":"1\u20132","key":"10.1016\/j.thromres.2011.01.009_bb0110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cccn.2005.07.007","article-title":"Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease","volume":"364","author":"Yang","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.thromres.2011.01.009_bb0115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1160\/TH06-04-0228","article-title":"Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia","volume":"96","author":"Undas","year":"2006","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.thromres.2011.01.009_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-2007-995837","article-title":"Fibrinogen structure and fibrin clot assembly","volume":"24","author":"Mosesson","year":"1998","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.thromres.2011.01.009_bb0125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0037-1613368","article-title":"Molecular mechanisms of initiation of fibrinolysis by fibrin","volume":"89","author":"Medved","year":"2003","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.thromres.2011.01.009_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0049-3848(00)00235-8","article-title":"Thrombotic dysfibrinogenemia. Fibrinogen \"Caracas V\" relation between very tight fibrin network and defective clot degradability","volume":"99","author":"Marchi","year":"2000","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.thromres.2011.01.009_bb0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal Biochem"},{"key":"10.1016\/j.thromres.2011.01.009_bb0140","first-page":"133","article-title":"Purification of fibrinogen","volume":"14","author":"Furlan","year":"1984","journal-title":"Curr Probl Clin Biochem"},{"issue":"8","key":"10.1016\/j.thromres.2011.01.009_bb0145","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1074\/jbc.274.8.5201","article-title":"The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin","volume":"274","author":"Walker","year":"1999","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.thromres.2011.01.009_bb0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/bit.10001","article-title":"Mechanism of bovine serum albumin aggregation during ultrafiltration","volume":"75","author":"Maruyama","year":"2001","journal-title":"Biotechnol Bioeng"},{"issue":"8","key":"10.1016\/j.thromres.2011.01.009_bb0155","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1073\/pnas.89.8.3478","article-title":"Abnormal fibrinogens IJmuiden (B beta Arg14\u2013\u2013Cys) and Nijmegen (B beta Arg44\u2013\u2013Cys) form disulfide-linked fibrinogen-albumin complexes","volume":"89","author":"Koopman","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.thromres.2011.01.009_bb0160","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1172\/JCI116371","article-title":"Molecular basis for fibrinogen Dusart (A alpha 554 Arg\u2013>Cys) and its association with abnormal fibrin polymerization and thrombophilia","volume":"91","author":"Koopman","year":"1993","journal-title":"J Clin Invest"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T14:21:05Z","timestamp":1592317265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0049384811000363"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.01.009","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}